MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Serum cholesterol level is associated with risk of MSA

YC. Lu, MC. Kuo, RM. Wu (Taipei, Taiwan)

Meeting: 2018 International Congress

Abstract Number: 978

Keywords: Alpha-synuclein, Lipid metabolism, Multiple system atrophy(MSA): Pathophysiology

Session Information

Date: Sunday, October 7, 2018

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: We aim to ascertain the association between serum cholesterol and multiple system atrophy (MSA).

Background: MSA, a common form of atypical parkinsonism, is a rapidly progressive neurodegenerative disease characterized by a combination of symptoms that affect both the autonomic nervous system and movement. The hallmark of MSA is the glial cytoplasmic inclusion (GCI) with aggregation and deposition of α-synuclein. Deranged cholesterol metabolism have been found in many neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease.

Methods: This is a cohort study for investigation of lipid metabolism in MSA in a Taiwanese population. The patients fulfilled with the criteria of possible and probable diagnosis of MSA were enrolled in the special clinics of Movement disorders in one medical center of Taiwan. The functional scores (UMSARS, MDS-UPDRS), epidemiological questionnaire and BMI were evaluated. Serum total cholesterol (T-CHO) and triglyceride (TG) were examined. Healthy controls are obtained from Taiwan Biobank. Subjects in Taiwan Biobank less than 60 years old or with major diseases will be excluded. In the end, 234 subjects were included as healthy controls for analyses.

Results: 100 MSA patients participated in this study. The demographic data of the MSA group are 53 men, 47 women; 73 MSA-P, 27 MSA-C; mean age of onset, 63.4 years; median of disease duration, 4.7 years. In particular, the T-CHO levels are significantly lower in 100 MSA patients compared with 234 healthy controls (176.4 ± 40.4 vs. 200.4 ± 35.8, p<0.0001). The T-CHO levels are even lower in MSA-P (171.6 ± 40.4) compared with MSA-C (189.8 ± 41.0). Nevertheless, the TG levels had no difference among patients and control (116.7 ± 67.3 vs. 115.5 ± 61.1, p=0.931). We performed a stepwise multiple logistic regression analysis and discovered that lower cholesterol level was significantly correlated with risk of developing MSA (p<0.0001, adjusted odds ratio = 0.975, 95% CI = 0.966 - 0.985).

Conclusions: The T-CHO level is negatively correlated with MSA risk. Whether systemic lipid metabolism is connected with myelin degradation and α-synucleinopathy in MSA deserves further investigation.

To cite this abstract in AMA style:

YC. Lu, MC. Kuo, RM. Wu. Serum cholesterol level is associated with risk of MSA [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/serum-cholesterol-level-is-associated-with-risk-of-msa/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/serum-cholesterol-level-is-associated-with-risk-of-msa/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley